Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders-Reference-Cited by-同舟云学术

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders

Published:2017-05-25 Issue:7 Volume:32 Page:1537-1538
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:

Author:

Humaidan P.¹²,Chin W.³,Rogoff D.⁴,D'Hooghe T.⁵,Longobardi S.⁵,Hubbard J.⁴,Schertz J.⁴

Affiliation:

1. The Fertility Clinic, Skive Regional Hospital, Skive, Denmark

2. Faculty of Health, Aarhus University, Aarhus, Denmark

3. Global Biostatistics and Epidemiology, EMD Serono, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany

4. Global Clinical Development, EMD Serono Research and Development Institute, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany

5. Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/32/7/1537/24804172/dex208.pdf

Reference3 articles.

1. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria;Ferraretti;Hum Reprod,2011

2. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision;Ferraretti;Hum Reprod,2014

3. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice;La Marca;Hum Reprod Update,2014

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human luteinizing hormone increases endometrial thickness in women undergoing assisted fertility treatments: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-07-29

2. Management strategies for POSEIDON patients with poor ovarian response to ovarian stimulation: а literature review;Journal of obstetrics and women's diseases;2024-05-27

3. Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy?;Frontiers in Endocrinology;2024-02-07

4. The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders;Archives of Gynecology and Obstetrics;2023-12-05

5. Exploring the Impact of Controlled Ovarian Stimulation and Non-Invasive Oocyte Assessment in ART Treatments;Life;2023-09-29